Dinner for participants by the invitation and sponsorship of the Mayor of the City of Krakow *
* Declaration from the Organizers: No resources from INFARMA associated companies are involved.
08.30 – 09.15
Targeted therapies with companion diagnostics in the management of cancer patients: future perspectives. – I. Ługowska
09.15 – 10.00
Next generation molecular board for functional precision medicine. – M. Kamal
10.00 – 10.30
Coffee (30’)
10.30 – 11.15
Cancer of unknown origin. – A. Bellizzi
11.15 – 12.00
Cancers of Unknown Primary Site: Clinical and Molecular Approach. – K. Tałasiewicz
12.00 – 13.00
Lunch (60’)
13.00 – 13.45
Immunohistochemical detection of predictive biomarkers for molecularly targeted therapies and immunotherapies. – J. Lasota
13.45 – 14.30
Immunohistochemistry of Head and Neck tumors. – A. Bellizzi
14.30 – 15.00
Coffee (30’)
15.00 – 15.30
AI and Digital Pathology – K. Korski
15.30 – 16.00
Digital analysis of predictive factors in breast cancer – A. Kowalewski
16.00 – 16.15
Summary and conclusions – J. Ryś
08.30 – 09.15
Histological, Immunohistochemical and Molecular Subtypes of TNBC – G. Cserni
09.15 – 10.00
HER2- High and Low Breast Cancer – T. Tot
10.00 – 10.30
Coffee (30’)
10.30 – 11.15
Histological, Immunohistochemical and Molecular Approach to Differential Diagnosis of Pulmonary Malignant Neoplasms – A. Nicholson
11.15 – 12.00
IHC based predictive biomarkers for solid tumors (novel PD-L1 applications, claudin 18 and Ceacam 5) – H-U. Schildhaus
12.00 – 12.30
Tuft Cell-like Carcinoma. The New Kid on the Block – J. Lasota